EDTUTC-4 New YorkLog in Sign up

LABT
Lakewood-Amedex Biotherapeutics Inc. Common Stock
stockNASDAQ

At CloseOct 16, 2026 3:59:44 PM EDT

0.59USD-5.039%(+0.59)63,421

Pre-marketOct 16, 2026 9:28:30 AM EDT

0.635USD-7.990%(-0.055)

After-hoursOct 16, 2026 4:48:30 PM EDT

0.58USD-0.973%(-0.01)

Loading…

Loading…

1.39M

Previous Close

$0.61

Beta

-0.66

52-Week High

$98.20 2026-04-23

52-Week Low

$0.58 2026-10-16

SMA 50

$1.77

SMA 200

$7.78

Avg. Vol 10D

993,414

Avg. Vol 30D

1.83M

Avg. Vol 90D

1.85M

Relative Vol

0.04

2.37M

283,275

11.95%

130,722

Short Interest %

46.15%

1.00

On/Off Exchange

44%/56%

16.91%

Short Vol % (off-exch)

12.85%

501.8700%

6,000

20,134

36,701

218,302

Nov 12, 2026 (26d)

Jun 22, 2026 · 1-for-10 (reverse)

Oct 7, 2026

08:02 AM EDTLakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds ·

PR Newswire

Oct 1, 2026

08:02 AM EDTLakewood-Amedex Biotherapeutics Announces Participation in October Conferences ·

PR Newswire

Sep 28, 2026

12:16 PM EDTLABT: First Patient Dosed in Phase 2a Trial of Nu-3 for Infected Diabetic Foot Ulcers ·

Zacks Small Cap Research

08:02 AM EDTLakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers ·

PR Newswire

Sep 24, 2026

08:02 AM EDTLakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers ·

PR Newswire

LABT Performance

Period	Price	Date	Change	Beta
1W	0.78	2026-10-09	-25.20%	2.180
1M	1.86	2026-09-17	-68.54%	5.603
3M	1.89	2026-07-17	-69.04%	1.154
6M	86.50	2026-04-23	-99.32%	-0.655

LABT Stock Summary

Lakewood-Amedex Biotherapeutics Inc. Common Stock (NASDAQ:LABT) stock price today is $0.59, and today's volume is 65,999. LABT is down 4.458% today. The 30 day average volume is 1.83M. LABT market cap is $1.39M with 2.37M shares outstanding.